13F Data
13F filer · CIK 1131399

GSK plc

London, X0 · filing since Q4 2025 · last filing Nov 5, 2026
Reported value
$497.0M
$-105.2M vs prior
Positions
13
New / sold out
1 / 1
Added / reduced
0 / 2
Turnover
12.3%
buys $67.5M · sells $161.6M
Top-10 weight
98.1%

Biggest buys vs Q2 2026

ChangeSecurityShares changeChange %Est. trade value
NewWAVE LIFE SCIENCES INC+18,245,691–+$67.5M

Biggest sells vs Q2 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outWAVE LIFE SCIENCES LTD-18,245,691-100.0%$-106.0M
ReducedCRISPR THERAPEUTICS AG-612,208-19.0%$-33.9M
ReducedBIONTECH SE-221,298-24.9%$-21.8M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2025: $799.0MQ1 2026: $599.2MQ2 2026: $602.2MQ3 2026: $497.0M
Q4 2025Q3 2026

Holdings · Q3 2026

#SecuritySharesValueWeight
1CRISPR THERAPEUTICS AGNAMEN AKT2,608,419$144.3M29.03%
2VIR BIOTECHNOLOGY INCCOM8,550,954$95.6M19.23%
3WAVE LIFE SCIENCES INCSHS18,245,691$67.5M13.58%
4BIONTECH SESPONSORED ADS668,526$65.7M13.22%
5IDEAYA BIOSCIENCES INCCOM1,333,333$51.2M10.31%
6CYTOKINETICS INCCOM NEW340,434$22.4M4.51%
7LYELL IMMUNOPHARMA INCCOM NEW1,512,659$14.8M2.98%
8SPERO THERAPEUTICS INCCOM9,190,606$11.1M2.24%
9NKARTA INCCOM3,150,732$8.3M1.66%
10FULCRUM THERAPEUTICS INCCOM1,785,714$6.6M1.33%
3 more rows. Subscribe for $29/month to see every row, download the data and use the API.